Fairbanks Pharmaceuticals to compete in semifinals of Diabetes Innovation Challenge

Fairbanks Pharmaceuticals has been selected as a semi-finalist in the Diabetes Innovation Challenge sponsored by the T1D Exchange, the Massachusetts Medical Device Development Center (M2D2) at UMass, the Juvenile Diabetes Research Foundation (JDRF) and the American Diabetes Association (ADA).

The Challenge is a proposal- and presentation-based competition for small companies in the T1 and T2 space that are making real progress towards better outcomes for those diagnosed.  It offers the chance to win in-kind awards and receive early and later-stage validation of their ideas and products specific to Type 1 and Type 2 diabetes.

Read more about the Challenge, or come see  us at UMass Lowell on October 5th, 2016 at the pre-clinical “pitch-off.”